Small cell lung cancer, current treatment and perspectives

Article Properties
Cite
Pešek, Miloš. “Small Cell Lung Cancer, Current Treatment and Perspectives”. Onkologie, vol. 17, no. 3, 2023, pp. 175-9, https://doi.org/10.36290/xon.2023.035.
Pešek, M. (2023). Small cell lung cancer, current treatment and perspectives. Onkologie, 17(3), 175-179. https://doi.org/10.36290/xon.2023.035
Pešek, Miloš. “Small Cell Lung Cancer, Current Treatment and Perspectives”. Onkologie 17, no. 3 (2023): 175-79. https://doi.org/10.36290/xon.2023.035.
Pešek M. Small cell lung cancer, current treatment and perspectives. Onkologie. 2023;17(3):175-9.
Refrences
Title Journal Journal Categories Citations Publication Date
Talazoparib and low-dose temozolomide in treating participants with relapsed or refractory extensive-stage small cell lung cancer. ClinicalTrials.gov. Updated 2022;February 82 2022
PL02.11 Overall Survival with Durvalumab Plus Etoposide-Platinum in First-Line Extensive-Stage SCLC: Results from the CASPIAN Study Journal of Thoracic Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
  • Medicine: Medicine (General)
 16 2019
10.1200/JCO.1999.17.2.658
10.1200/JCO.2008.20.1061
Second-line chemotherapy and its evaluation in small cell lung cancer Cancer Treatment Reviews
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 42 1999